Back to results
US 2014/0228416 A1Published application
Substituted hydroxamic acids and uses thereof
AssigneeMillennium Pharmaceuticals, Inc.
InventorsChristopher Blackburn, Kenneth M. Gigstad, He Xu
Life of this patent
Estimating the term…
Abstract
This invention provides compounds of formula (I): wherein X1, X2, X3, R2, R4b, R1, and G have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.
Claims26
A compound of formula (I):
- or a pharmaceutically acceptable salt thereof;
- wherein:
- ring A is a heteroaromatic 5-membered ring connected through one of positions (a) or (b);
- X1 is CR1, O, or S;
- (i) when ring A is connected through position (a), X2 is C;
- and X3 is CR1, O, S, or N;
- or
- (ii) when ring A is connected through position (b), X3 is C;
- and X2 is CR1, O, S, or N;
- provided that only one of X1, X2, or X3 is O or S;
- and further provided that at least one of X1, X2, and X3 is O, S, or N;
- each occurrence of R1 is independently hydrogen, halogen, C1-4 alkyl, C1-3 fluoroalkyl, —O—C1-3 alkyl, —O—C1-3 fluoroalkyl, cyano, hydroxy, —NHC(O)C1-3 alkyl, —C(O)NHC1-3 alkyl, —NHC(O)NHC1-3 alkyl, or —NHS(O)2C1-3 alkyl;
- ring A is further substituted at a substitutable nitrogen atom with R1a;
- R1a is hydrogen, or C1-4 aliphatic;
- R2 is C1-6 aliphatic, C1-6 fluoroaliphatic, or unsubstituted or substituted 6-10-membered aryl;
- R4b is hydrogen, or C1-4 aliphatic;
- G is —R3, —V1—R3, —V1-L1-R3, -L2-V1—R3, -L2-V2—R3,
- L1 is an unsubstituted or substituted C1-3 alkylene chain;
- L2 is an unsubstituted or substituted C2-3 alkylene chain;
- V1 is —C(O)—, —C(O)—CRA═CRA—, —C(O)—N(R4a)—, —C(O)—O—, or —S(O)2—;
- V2 is —C(S)—, —N(R4a)—, —N(R4a)—C(O)—, —SO2—N(R4a)—, —NR4a)—SO2—, —O—, —S—, —S(O)—, NR4a)—C(O)—NR4a)—, —N(R4a)—C(O)—O—, —O—C(O)—N(R4a)—, or —N(R4a)—SO2—N(R4a)—;
- R3 is unsubstituted or substituted C1-6 aliphatic, unsubstituted or substituted 3-10-membered cycloaliphatic, unsubstituted or substituted 4-10-membered heterocyclyl having 1-5 heteroatoms independently selected from nitrogen, oxygen, and sulfur, unsubstituted or substituted 6-10-membered aryl, or unsubstituted or substituted 5-10-membered heteroaryl having 1-5 heteroatoms independently selected from nitrogen, oxygen, and sulfur;
- each occurrence of RA is independently hydrogen, fluoro, or unsubstituted or substituted C1-4 aliphatic;
- and
- each occurrence of R4a is independently hydrogen, or unsubstituted or substituted C1-4 aliphatic.
22 more elements
Dependencies are inferred from the claim text.